JoelMNeutelMD

Clinical Trials

• Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18

  Completed

  Phase 3

• Efficacy and Safety of Human Neuregulin-1 to Treat Stable Chronic Heart Failure Start of enrollment: 2012 Jan 01

  Completed

  Phase 2

• Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects Start of enrollment: 2013 Jan 01

  Unknown status

  Phase 2

• Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers Start of enrollment: 2013 Feb 01

  Terminated

  Phase 3

• Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use Start of enrollment: 2015 Dec 01

  Terminated

  Phase 3

• A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure Start of enrollment: 2013 Sep 01

  Completed

  Phase 1

• A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics Start of enrollment: 2014 Mar 01

  Completed

  Phase 2

• Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus Start of enrollment: 2015 Jul 27

  Completed

  Phase 2

• Finasteride Treatment of Severe Nodulocystic Acne Start of enrollment: 2015 Jul 01

  Completed

  Phase 2

• A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) Start of enrollment: 2016 Jan 21

  Completed

  Phase 3

• Glycemic Response to Three Oral Nutrition Supplements in Persons With Type 2 Diabetes Mellitus Start of enrollment: 2016 Jul 01

  Completed

  Not Applicable

• Glycemic Response to Two Enteral Formulas in Persons With Type 2 Diabetes Mellitus Start of enrollment: 2016 Aug 01

  Completed

  Not Applicable

• A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus Start of enrollment: 2016 Oct 01

  Completed

  Phase 2

• Glycemic Response to Six Meal Replacements in Persons With Type 2 Diabetes Mellitus Start of enrollment: 2017 Apr 05

  Completed

  Not Applicable

• Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis Start of enrollment: 2017 Sep 19

  Completed

  Phase 1, Phase 2

• A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus Start of enrollment: 2018 May 29

  Completed

  Phase 2

• A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function Start of enrollment: 2018 Mar 30

  Completed

  Phase 1

• A Safety Study of Tucatinib in Healthy and Hepatically-Impaired Subjects Start of enrollment: 2018 Oct 10

  Completed

  Phase 1

• A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise Healthy Start of enrollment: 2018 Oct 10

  Recruiting

  Phase 1

• Glycemic Response in Persons With Type 2 Diabetes Mellitus Start of enrollment: 2018 Feb 05

  Completed

  Not Applicable

• A Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes Mellitus Start of enrollment: 2020 Nov 23

  Completed

  Phase 2

• Pharmacokinetic and Safety Study of Naltrexone Release From Subcutaneous BICX104 Pellets Compared to Vivitrol Injections Start of enrollment: 2022 Jun 17

  Completed

  Phase 1

  Roles: Contact

• Join now to see all